Previous 10 | Next 10 |
BILLERICA, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient ...
Gainers: Teekay Offshore Partners L.P. (NYSE: TOO ) +32% . BioCardia ( OTCQB:BCDA ) +25% . Roan Resources (NYSE: ROAN ) +21% . Conformis (NASDAQ: CFMS ) +18% . Constellation Pharmaceuticals (NASDAQ: CNST ) +15% . Pintec Technology Holdings (NASDAQ: PT ) +13% . Geron Corporation...
BILLERICA, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient...
Editor's note: Seeking Alpha is proud to welcome Carolina Doc as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more » Carolina Doc is a...
Conformis, Inc. (CFMS) Q2 2019 Earnings Conference Call July 31, 2019, 04:30 PM ET Company Participants Mark Augusti - President and CEO Paul Weiner - CFO Conference Call Participants Ryan Zimmerman - BTIG Josh Jennings - Cowen Kyle Rose - Canaccord Amir Bashar - Oppen...
Conformis (NASDAQ: CFMS ) -37% on softer revenue outlook . More news on: Conformis, Inc., Pluralsight, Inc., Whiting Petroleum Corporation, Stocks on the move, Read more ...
Conformis (NASDAQ: CFMS ) slumps 38% premarket on modest volume in reaction to its guidance for flat revenue growth this year due mainly to denials of coverage from Aetna, adding that the rate of denials has "increased substantially" in the last few months. The company says it ...
ConforMIS (NASDAQ: CFMS ): Q2 GAAP EPS of -$0.11 beats by $0.01 . More news on: Conformis, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
BILLERICA, Mass., July 31, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's uni...
BILLERICA, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's un...
News, Short Squeeze, Breakout and More Instantly...
BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the second quarter ended June 30, 2022, after the mark...
BILLERICA, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced results of a published study that investigated the characteristic shapes of knees to see if typica...
BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will part...